
As 2024 winds down, we're looking back on some of the stories that caught readers' eyes on Contagion related to the variety of hepatitis virus infections.
As 2024 winds down, we're looking back on some of the stories that caught readers' eyes on Contagion related to the variety of hepatitis virus infections.
In the second installment of the RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.
The Biden Administration addresses antimicrobial resistance with new project, company voluntarily recalls its antifungal, and a fatal case of the plague is reported in the US.
Check out these important stories we covered this past week.
The full approval is based on 3 randomized controlled trials showing benefit of remdesivir compared with placebo across multiple outcome assessments.
Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the impact of COVID-19 on hospitals around the country.
The CRL requests that Nabriva address issues related to facility inspections and manufacturing deficiencies at one of Nabriva’s contract manufacturers prior to the FDA approving the New Drug Application.
The broad-spectrum investigational antibiotic has been developed for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
The FDA has approved Allergan's sNDA to expand the approved use of AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by certain susceptible Gram-negative microorganisms.
The fluoroquinolone exhibits activity against both gram-positive and gram-negative pathogens, including methicillin-resistant Staphylococcus aureus, and is available in both intravenous and oral formulations.
The results of a new CDC Morbidity and Mortality Weekly Report revealed that in US states and territories with local Zika virus transmission, the prevalence of Zika-related birth defects is increasing.
A total of 22 cases of yellow fever have been confirmed in Minas Gerais since July 2017 and 15 of those individuals have died.
Silvia Munoz-Price, MD, PhD, calls for more microbiome research in order to ultimately improve patient care in hospitals.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
A total of 5 HIV cure research initiatives will receive $7.5 million as recipients of Gilead’s HIV cure grants program.
The declaration was made to help direct funds towards controlling the outbreak and providing adult hepatitis A vaccines to those in need.
New CDC Morbidity and Mortality Report highlights gaps in infection control practices in many New York City hospitals.
A new study looks at the role the microbiome of the middle ear may play in ear infections.
Despite clearing the virus, researchers find that Ebola survivors can suffer long-term effects of infection.
Presentations at the 21st Annual USCA Conference shed light on the fact that although overall rates of HIV are decreasing, some populations are seeing a startling increase.
New research on the Zika virus, how ticks are helping us learn more about HIV, and a rare mosquito-borne virus that has sprung up in the United States, round out the topics for our Top 5 articles of the week.
New research has shown that the devastating effects of the Zika virus on the newborn brain may be the key to destroying glioblastoma in adults.
Potentially defective personal protection equipment, patients’ involvement in hand hygiene, probiotics that work against C. difficile, what makes delafloxacin unique, and a new discovery against the herpes virus make up the Top 5 articles for the month of August 2017.
The new test examines proteins and peptides in saliva using proteomics, the study of proteomes and their functions.
Jessica Justman, MD, shares why the Population-based HIV Impact Assessment Project is so important.
Daniel Pilch, PhD, explains which patients would not make good candidates for MRSA prodrug TXA709.
Stay up-to-date on the latest infectious disease news by checking out this snapshot of our top 5 articles of the week.
Edmond LaVoie, PhD, shares different approaches that can be used to forestall the development of antibiotic resistance.
A new study is disputing previous findings that the Zika virus persists in semen for up to 188 days.
Those US residents affected by Hurricane Harvey need to be mindful of rodent-borne infections that can spread from displaced rodents.
Published: December 15th 2023 | Updated:
Published: March 18th 2022 | Updated:
Published: November 19th 2016 | Updated:
Published: November 19th 2016 | Updated:
Published: November 20th 2016 | Updated:
Published: November 22nd 2016 | Updated: